Argen X SE - ADR

NASDAQ:ARGX

543.48

-1.63 (-0.30%)

1:43:17 PM EDT: $543.48 0.00 (0.00%)

Market Cap (Intraday)	33.09B
Current PE	31.09
Forward PE	42.29
2yr Forward PE	25.66

See more stats

Estimates Current Quarter

Revenue	$871.11 Million
Adjusted EPS	$2.98

See more estimates

10-Day MA	N/A
50-Day MA	N/A
200-Day MA	N/A

See more pivots

Argen X SE - ADR Stock, NASDAQ:ARGX

Laarderhoogtweg 25, Amsterdam, Noord-Holland 1101 EB

Belgium

Phone: +31.76.303.04.88

Number of Employees: 1148

http://www.argen-x.com

Description

argenx SE is a global immunology company, which engages in improving the lives of people suffering from severe autoimmune diseases. It operates through the following geographical segments: United States, Japan, EMEA, and China. The company was founded by Hans J. W. de Haard, Torsten Dreier, and Tim van Hauwermeiren in 2008 and is headquartered in Amsterdam, the Netherlands.